Characterization of macrolide resistance genes in Haemophilus influenzae isolated from children with cystic fibrosis

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 1, 2011, Pages 100-104

  Roberts, Marilyn C ^a   Soge, Olusegun O ^a   No, David B ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Azithromycin resistance; Macrolides; Mobile erm and mef(A) genes

Indexed keywords

AZITHROMYCIN; ERYTHROMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHILD; CYSTIC FIBROSIS; ENTEROCOCCUS FAECALIS; GENE MUTATION; GENE TRANSFER; HAEMOPHILUS INFLUENZAE; HUMAN; MACROLIDE RESISTANCE GENE ERM(A); MACROLIDE RESISTANCE GENE ERM(B); MACROLIDE RESISTANCE GENE ERM(C); MACROLIDE RESISTANCE GENE ERM(F); MACROLIDE RESISTANCE GENE MEF(A); MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CONJUGATION, GENETIC; CYSTIC FIBROSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENE TRANSFER, HORIZONTAL; GENES, BACTERIAL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEQUENCE ANALYSIS, DNA;

EID: 78650403480     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq425     Document Type: Article

References (23)

1. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 2007; 20: 368-89.
2. Razvil S, Quittell L, Sewall A et al. Respiratory microbiology of patients with cystic fibrosis in the United States. Chest 2009; 136: 1554-60.
3. Phaff SJ, Tiddens HA, Verbrugh H et al. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis. J Antimicrob Chemother 2006; 57: 741-6.
4. Saiman L, Marshall BC, Mayer-Hamblett N et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2003; 290: 1749-56.
5. Tazumi A, Maeda Y, Goldsmith CE et al. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF). J Antimicrob Chemother 2009; 64:1-6.
6. Peric M, Bozdogan B, Jacobs MR et al. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimicrob Agents Chemother 2003; 47: 1017-22.
7. Clark C, Bozdogan B, Peric M et al. In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin. Antimicrob Agents Chemother 2002; 46: 2956-62.
8. Roberts MC, Beck N, White T et al. Acquired macrolide resistance genes in high-level macrolide resistant H. influenzae isolates from a cystic fibrosis patient. In: Abstracts of the Forty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco CA, 2006. Abstract C2-1339, p. 131. American Society for Microbiology, Washington, DC, USA.
9. Roe DE, Weinberg A, Roberts MC. Characterization of erythromycin resistance in Campylobacter (Wolinella) rectus. Clin Infect Dis 1995; 20: S370-1.
10. Roberts M, Chung WO, Roe D et al. Erythromycin resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes. Antimicrob Agents Chemother 1999; 43: 1367-72.
11. Roberts MC, Smith AL. Molecular characterization of "plasmid-free" antibiotic resistant Haemophilus influenzae. J Bacteriol 1980; 144: 476-9.
12. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
13. Andrews JM. BSAC standardized disc susceptibility testing method (version 8). J Antimicrob Agents 2009; 64: 454-89.
14. Soge OO, Tivoli LD, Meschke JS et al. A conjugative macrolide resistance gene, mef(A), in environmental Clostridium perfringens carrying multiple macrolide and/or tetracycline resistance genes. J Appl Microbiol 2009; 106: 34-40.
15. Soge OO, Meschke JS, No DB et al. Characterization of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative Staphylococcus spp. (MRCoNS) isolated from West Coast public marine beaches. J Antimicrob Chemother 2009; 64: 1148-55.
16. Ross JI, Eady EA, Cove JH et al. Minimal functional system required for expression of erythromycin resistance by msrA in Staphylococcus aureus RN4220. Gene 1996; 183: 143-8.
17. Roberts MC. Plasmid-mediated TetM in Haemophilus ducreyi. Antimicrob Agents Chemother 1989; 33: 1611-3.
18. Roberts MC. Update on macrolide-lincosamide-streptogramin, ketolide and oxazolidinone (MLSKO) resistance genes. FEMS Microbiol Lett 2008; 282: 147-59.
19. Nagai H, Shishido H, Yoneda R et al. Long-term low dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 1991; 58: 145-9.
20. Jaffe A, Francis J, Rosenthal M et al. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet 1998; 351: 420.
21. Hansen CR, Pressler T, Hoiby N et al. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients. J Cyst Fibrosis 2009; 8: 58-62.
22. Tramper-Stranders GA, Wolfs TFW, Fleer A et al. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis. Pediatr Infect Dis J 2007; 26: 8-12.
23. Ojo KK, Ulep C, Van Kirk N et al. The mef(A) gene predominates among seven macrolide resistance genes identified in gram-negative strains representing 13 genera, isolated from healthy Portuguese children. Antimicrob Agents Chemother 2004; 48: 3451-6.